Bazaar News
BizToc
[ad_1]
Novo Nordisk A/S drugs that are commonly used for weight loss were linked to a higher risk of bowel obstructions and other gastrointestinal side effects in patients with obesity than an older treatment. Using a health database, researchers compared side effects from Novo’s drugs such as Ozempic,…
#novonordiskas #novo #ozempic #saxenda #glp1s #glp1 #novonordisk #jama #novonordiskamerican #wegovyandelilillycos
[ad_2]
